article · Gut Pathogens
Research conducted in the Nile Delta region of Egypt reports the presence of colistin resistance and the emergence of multidrug resistance in Enterobacteriaceae recovered from healthy broiler chickens. The investigation identifies colistin-resistant Escherichia coli and extended-spectrum beta-lactamase (ESBL)-producing strains within poultry flocks. Because extended-spectrum beta-lactamase and carbapenemase-producing Gram-negative bacteria are escalating globally, detecting these strains in farmed birds raises concerns regarding transmission pathways to human populations. The findings highlight an urgent requirement for intensified pathogen surveillance in agricultural settings, alongside the design and enforcement of dedicated control measures aimed at curtailing antibiotic use in poultry management.
The identification of colistin resistance and multidrug-resistant bacteria in farm animals is a serious public health issue. Colistin serves as an antibiotic of last resort for human infections. Finding resistant pathogens in healthy poultry points to food production systems as potential sources for resistant bacteria entering the wider community, underscoring the necessity of stricter antibiotic regulation in farming.
The abstract does not indicate an application pathway, as it focuses strictly on reporting surveillance findings regarding resistant bacterial strains.
AI-generated from the published abstract. Always read the original work before citing.
This is the first study reporting colistin resistance and emergence of multidrug resistance in <i>Enterobacteriaceae</i> isolated from healthy broilers in the Nile Delta region, Egypt. Colistin-resistant <i>E. coli</i> in poultry is of public health significance. The global rise of ESBL- and carbapenemase-producing Gram-negative bacteria demands intensified surveillance. ESBL-producing <i>E. coli</i> in poultry farms in Egypt are of major concern that emphasizes the possibility of spread of such strains to humans. The results also reinforce the need to develop strategies and to implement specific control procedures to reduce the use of antibiotics.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1186/s13099-018-0266-5
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
